Price
CHART BY
Frequently asked questions
What is Paxman's market capitalization?
The market capitalization of Paxman is SEK 1.14B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Paxman?
Paxman's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.746. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Paxman's stock?
Currently, 1 analysts cover Paxman's stock, with a consensus target price of SEK 103.00. Analyst ratings provide insights into the stock's expected performance.
What is Paxman's revenue over the trailing twelve months?
Over the trailing twelve months, Paxman reported a revenue of SEK 313.35M.
What is the EBITDA for Paxman?
Paxman's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is SEK 28.91M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Paxman?
Paxman has a free cash flow of -SEK 8.19M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Paxman have, and what sector and industry does it belong to?
Paxman employs approximately 144 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
What is the free float of Paxman's shares?
The free float of Paxman is 14.19M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- SEK 1.14B
- EPS (TTM)
- -$0.746
- Free Float
- 14.19M
- Revenue (TTM)
- SEK 313.35M
- EBITDA (TTM)
- SEK 28.91M
- Free Cashflow (TTM)
- -SEK 8.19M
Pricing
- 1D span
- $5.126$5.331
- 52W span
- $4.503$8.965
Analyst Ratings
The price target is SEK 103.00 and the stock is covered by 1 analysts.
Buy
1
Hold
0
Sell
0
Information
Paxman AB engages in the research and development of scalp cooling system. It focuses on its product, PAXMAN Scalp Cooling System, which is used to minimize hair loss in connection with chemotherapy treatment. The company was founded by Glenn Ann Paxman in 1996 and is headquartered in Karlshamn, Sweden.
- Employees
- 144
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- SE0009806284
- Primary Ticker
- PAX
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet